Market revenue in 2023 | USD 41.9 million |
Market revenue in 2030 | USD 91.9 million |
Growth rate | 11.9% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 59.19% in 2023. Horizon Databook has segmented the Japan microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has one of the largest geriatric populations in the world, which is a leading cause of higher incidence of clinical disorders, thus contributing to the lucrative growth of the microbiome sequencing services market. Most of the academic institutions in Japan have conducted detailed investigations regarding the value and feasibility of clinical sequencing.
In addition, cancer societies have issued consensus clinical practice guidance for NGS-based gene panel tests. These have facilitated the implementation of genomic medicine for cancer in Japan.
Moreover, the Japan Microbiome Consortium (JMBC) was established in the country to enhance the commercialization of human microbiome research. The consortium was set up with the objectives of standardizing microbiome measurement and the creation of a microbiome database in Japan. Initiatives such as these are expected to propel market growth for Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into Japan microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account